Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

American biotechnology firm Regeneron Pharmaceuticals is buying the personal genetics brand 23andMe after submitting a winning bid of $256 million in a bankruptcy auction, according to a Monday ...

Being spliced on to Regeneron will free the genetic testing company from its fatal dependence on sporadic revenue ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...

The insolvent genetic analysis company 23andme is taken over by a pharmaceutical company that wants to continue the business ...

South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting ...

On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...